Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $17.60 -6.03%
EPS Growth %: +17.6%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +17.6%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $55.2 million versus the consensus estimate of $55.28 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- BIG3 Basketball to go public via Graf Global merger at $290 million
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
